The global pressure-infusion-bags market is projected to grow from USD 388.2 million in 2025 to about USD 707.7 million by 2035 at a 6.2% CAGR through 2035. Trauma and emergency-medicine caseloads continue to climb worldwide-road-traffic injuries alone are expected to top 100 million annually by 2030-keeping rapid fluid resuscitation protocols front-and-centre in emergency rooms, field hospitals and combat-care settings.
The migration of surgeries to ambulatory and office-based centres fuels adoption of single-use, latex-free pressure cuffs that speed up contrast-media delivery and blood-product transfusion without bulky pressure pumps. Tighter infection-control standards following the COVID-19 era favour disposable clear-cuff bags that allow continuous fluid-level visibility and eliminate cross-contamination risk.
New wrap-around polyolefin films tolerate up to 325 mm Hg without ballooning, while RFID chips embedded in the pressure bulb log inflation cycles and alert clinicians to over-pressurisation. Start-ups are pairing bags with in-line pressure sensors that relay real-time data to anaesthesia workstations, meeting ISO 80369 connection standards and reducing inadvertent air embolism events.
Sustainability also enters the design brief--ICU Medical has piloted mono-material cuffs whose polypropylene shells and valves can be recycled together, trimming disposal costs under emerging extended-producer-responsibility rules in the EU and eight USA states.
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 360.3 million |
| Estimated Size, 2025 | USD 388.2 million |
| Projected Size, 2035 | USD 707.7 million |
| Value-based CAGR (2025 to 2035) | 6.2% |
North America retains the highest revenue share, buoyed by Level-1 trauma-centre requirements, Medicare reimbursement for ambulatory infusion devices and ongoing hospital stock-building for climate-disaster preparedness.
Europe shows strong uptake of EN ISO 13485-certified clear-cuff bags as NHS trusts and German Länder implement “single-use where clinically justified” guidelines. Asia Pacific is expected to grow the fastest CAGR (> 7 %) as India adds 40,000 new ICU beds under its National Health Infrastructure Mission and China raises emergency-care spending in Tier-2 cities.
Industry leaders underscore the growth narrative. Commenting on Q4-2024 results, ICU Medical CEO Vivek Jain noted that “infusion-system growth reflects normal market expansion and the benefit from Plum Duo implementations, particularly in the back half of the year,” signalling confidence that portfolio upgrades and safety-driven purchasing will sustain momentum. With rising trauma incidence, outpatient-surgery expansion and smart, recyclable designs converging, pressure-infusion bags are set for durable, innovation-led growth through 2035
In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 6.9%, followed by a slightly lower growth rate of 6.6% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 6.9% (2024 to 2034) |
| H2 | 6.6% (2024 to 2034) |
| H1 | 6.2% (2025 to 2035) |
| H2 | 5.7% (2025 to 2035) |
The above table presents the expected CAGR for the global pressure infusion bags market over several semi-annual periods spanning from 2025 to 2035. Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 6.9% in the first half and decrease moderately at 6.6% in the second half. In the first half (H1) the market witnessed a decrease of 70 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
Disposable pressure infusion bags are anticipated to dominate the market, capturing a significant market share of 65.2% in 2025. This dominance primarily arises from their capability to significantly reduce risks associated with cross-contamination and infections. In healthcare environments such as emergency rooms (ER), intensive care units (ICUs), and trauma centers, maintaining sterility during IV administration of medications, fluids, or blood products is crucial.
Disposable infusion bags eliminate the risk of pathogen transfer between patients, a significant concern associated with improperly sanitized reusable bags. Hospitals and clinics prefer disposable bags due to strict compliance requirements regarding patient safety and infection control.
Manufacturers continuously introduce innovative, sustainable disposable options that enhance both environmental responsibility and sterility, ensuring strong demand in this segment. Major companies like Merit Medical Systems and Smiths Medical continue to invest in developing disposable infusion bags with improved safety features, further solidifying this segment’s leading position in the pressure infusion bags market.
The blood & drug infusion segment is expected to lead significantly, holding approximately 73.1% market share in 2025. The prominence of this segment is driven by the necessity of rapidly delivering medications and blood products directly into the bloodstream, bypassing the digestive system
. Intravenous administration provides immediate therapeutic effects, crucial in emergency medical scenarios such as severe infections, sepsis, acute dehydration, or critical trauma. For example, during events such as septic shock, direct intravenous infusion allows swift fluid resuscitation and rapid medication administration, significantly improving patient outcomes.
The capability of delivering medications precisely and quickly makes blood and drug infusion critical in managing urgent medical conditions and chronic treatments requiring frequent, reliable intravenous interventions.
Rising incidence of acute health events and chronic illnesses increases demand for pressure infusion solutions, especially within critical care settings. Companies such as Becton Dickinson (BD) and Baxter International focus on developing advanced infusion systems tailored for rapid, precise, and safe drug delivery, ensuring continued growth and dominance of the blood & drug infusion segment in the healthcare market.
The Pressure Infusion Bags Market is growing amidst Increase in the Adoption of Pressure Infusion Bags as Rising Prevalence of Chronic Conditions
Increasing adoption of pressure infusion bags in hospitals and outpatient facilities, for rapid IV infusion, is expected to increase opportunities for manufacturers to expand and gain market share across the globe.
Earlier, the standard practice in hospitals was using IV fluids bags. Then came the pressure infusion bags, and these gained usage not only in hospitals but also outpatient clinics, long term care centers, and nursing facilities.
The use of pressure infusion bags expanded in patients suffering from severe trauma, gastrointestinal hemorrhage, postoperative hemorrhage, among other causes resulting in intravascular losses, like septic shock and burns.
Increase adoption of pressure infusion bags in hospitals and outpatient facilities attributed to its major two applications where bags used to pressurize sterile parenteral fluids for rapid infusion into the body as they decrease the infusion time to a few seconds as compared from an hour taken by gravity fed blood infusion and monitoring of invasive procedures useful in the patients who are likely to display sudden change in pressure.
Furthermore, pressure infusion bags are indispensable in treating patients with severe trauma, where rapid fluid resuscitation is essential to prevent hypovolemia and maintain perfusion to critical organs. They are equally crucial in managing gastrointestinal and postoperative hemorrhages, where significant blood loss necessitates the swift replacement of fluids or blood products.
Additionally, these bags are extensively used to address intravascular losses associated with septic shock and burns. Both conditions result in fluid deficits that require immediate replacement to stabilize the patient and prevent organ failure. By ensuring the rapid and controlled delivery of necessary fluids, pressure infusion bags play a vital role in managing these medical emergencies.
This ability of pressure infusion bags to deliver fluids rapidly and efficiently makes them essential for managing severe trauma, hemorrhages, septic shock, and burns, driving their widespread adoption across healthcare facilities.
Technology Innovations in Pressure Infusor Devices is Creating Opportunities for Pressure Infusion Bags Industry
Technology developments such as flush valve for regulating the blood flow of solutions, coupled with monitoring devices for checking regular blood pressure.
Pressure Infusor has also become a necessary component of invasive pressure monitoring procedures. Intra-arterial pressure monitoring and Swan-Ganz catheterization monitoring require the use of a pressurized plumbing system to retard the retrograde flow of blood.
Roller pump technology is a new technology innovation in pressure Infusor devices, and has been used to rapidly infuse blood or intravenous solution. Integrated with electromagnetic heater, air detector, and electronic flow control, high volumes of warmed fluids can be accurately delivered using this technology.
Emerging innovations, such as roller pump technology, are revolutionizing the market by enabling the rapid infusion of blood and intravenous solutions. This technology, often coupled with advanced features like electromagnetic heaters, air detectors, and electronic flow controls, allows for the delivery of high volumes of fluids that are warmed and precisely controlled.
These innovations are particularly critical in trauma settings or during surgical procedures where rapid fluid replacement is necessary to stabilize patients. The ability to deliver warmed fluids reduces the risk of hypothermia, a common complication during massive transfusions or fluid administration. Overall, these technological advancements not only improve the safety and efficiency of pressure infusion bags but also expand their applications in critical care and invasive monitoring.
Shortage of Skilled Professionals Hinders Pressure Infusion Bag Adoption and Market Expansion
There are two major clinical applications of pressure Infusor i.e. rapid infusion of blood, blood products & IV solutions and invasive pressure monitoring. Both of these applications involve intricate procedures where the proper operation of the device is paramount. The infusion of blood and other fluids requires precise calibration to ensure the correct pressure is applied, as excessive pressure can cause complications such as vascular damage, infiltration, or even organ dysfunction.
Pressure infusion device requires highly trained or skilled professionals to operate and monitor. Since majority of the complications can be attributed to the misuse of the device, such as incorrect calibration or interpretation of the pressure display, etc., high incidence of long term complications associated with invasive arterial blood pressure monitoring have also been reported.
The expertise of healthcare personnel operating the device directly links to the reliability and reproducibility of results. Errors in either calibration of the device, interpretation of results, or maintenance of the system shall seriously compromise efficacy and increase patient risk for adverse outcomes.
Thus, reliability and reproducibility of this instrument is highly dependent on skilled technicians or operators who interpret the results of pressure infusors. Overall, while pressure infusion bags offer significant benefits in critical care, overcoming the shortage of skilled professionals is essential to unlocking their full market potential.
The global pressure infusion bag industry recorded a CAGR of 6.8% during the historical period between 2020 and 2024. The growth of pressure infusion bag industry was positive as it reached a value of USD 360.3 million in 2024 from USD 277.1 million in 2020.
Historically, the global pressure infusion bag market has shown signs of steady growth at rather modest rates, as the healthcare industry moving toward more efficient life-sustaining technologies.
Classic IV fluid administration systems tended to be slow and inappropriate in patients with critical conditions for whom rapid infusion is of essence, such as traumatized and bleeding or shocked patients. As a result, pressure infusion bags were initially considered a specialized tool for critical care, particularly in emergency departments, trauma centers, and during surgical procedures.
For many years, conventional IV fluids, delivered via gravity-based systems, were the standard, making pressure infusion bags a secondary option due to their higher cost and perceived complexity.
In recent years, the market for pressure infusion bags has become revolutionized by technology advancements, intensively deep insight into clinical needs, and shifts in the practice of medicine and nursing. The current picture for the sales aspect is much brighter, with pressure infusion bags being widely used in a range of settings, including outpatient clinics, long-term care centers, nursing homes, and emergency response settings.
Modern pressure infusion bags have undergone technological advancements. Manufacturers have introduced bags with more precise pressure control, better durability, and enhanced compatibility with a wider range of sterile fluids and blood products.
The demand forecast suggests that pressure infusion bags will become even more mainstream in hospital settings, particularly in outpatient clinics, long-term care, and trauma units. The sales outlook points to an increasing shift towards multifunctional infusion systems that can handle diverse fluid types and integrate seamlessly with other patient care systems.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 55.5% in global market. These market leaders are characterized by high production capacity and a wide product portfolio.
These market leaders are distinguished by their extensive expertise in manufacturing and a broad geographical reach, underpinned by a robust consumer base. Prominent companies within tier 1 include Vyaire Medical Inc. Smiths Medical, Inc., Merit Medical Systems, Inc. and Salter Labs.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 24.2% market share. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include VBM Medizintechnik GmbH, AirLife, Statcorp Medical, and Spengler SAS among others.
Finally, Tier 3 companies, such as Rudolf Riester GmbH, Friedrich Bosch GmbH & Co. KG among others are essential for the market.
The section below covers the industry analysis for the pressure infusion bags market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The United States is anticipated to remain at the forefront in North America, with a value share of 93.6% through 2034. In Asia Pacific, South Korea is projected to witness a CAGR of 5.8% by 2034.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| Canada | 7.4% |
| Brazil | 4.3% |
| France | 4.5% |
| Russia | 6.9% |
| Japan | 7.9% |
| South Korea | 6.2% |
| Spain | 7.2% |
USA pressure infusion bags market is poised to exhibit a CAGR of 4.7% between 2024 and 2034. Currently, it holds the highest share in the North American market, and the trend is expected to continue during the forecast period.
The growth of chronic diseases such as cardiovascular disease and cancers have created demand for infusion pressure bags. According to the American Heart Association, cardiovascular diseases remain a leading cause of deaths, accounting for one-third of such deaths in the United States. Furthermore, according to article by the American Cancer Society, it's expected that in 2024, America will register over two million cases of new cancers.
These conditions, in many cases demanding long-term treatment with surgical or even emergency interventions, increase the risk of complications like severe bleeding, dehydration, or electrolyte disturbances in patients. Cancer treatments involving chemotherapy or surgeries can cause massive fluid imbalances or hemorrhages that require immediate fluid resuscitation.
Due to the increasing prevalence of chronic conditions, demand for pressure infusion bags is also expected to increase. This is expected to continue with increasing dependence on precision tools for fluid management, thus driving further advancements in pressure infusion technologies and making them an integral part of modern healthcare.
East Asia, spearheaded by China currently holds around 54.2% share of the East Asia pressure infusion bag industry. East Asia’s market is anticipated to grow at a CAGR of 7.7% throughout the forecast period.
The pressure infusion bags market in China is expected to grow considerably due to technological advancements, an evolving patient care landscape, and increasing healthcare infrastructure. One of these factors is the emerging industry focusing on developing new technologies, such as flush valves, to control the flow of solutions more accurately. This technology helps enhance fluid delivery in critical care situations, where precision is essential for maintaining patient stability.
Manufacturers in China are increasingly focusing on enhancing the design and functionality of pressure infusion bags. Many new products feature palm-fitted efficient hand bulbs with 3-way stopcock air valves, which make it easier for healthcare providers to operate the bags manually. These hand bulbs provide healthcare professionals with better control over the pressure, allowing for more precise infusion.
In summary, the drivers of the pressure infusion bags market in China include technological advancements, such as the development of flush valves, the adoption of high-quality materials like polyurethane and polyamide, and the focus on enhanced safety features.
UK is expected to have a strong foothold when it comes to technology innovation. In 2024 the country is projected to account for almost 14.5% of the Western European pressure infusion bags market.
Changes in the healthcare sector and growing need for home care services in the UK drive the growth of the pressure infusion bags market. The continuous shift in the health system of the UK toward home-based treatment and recovery for the patients is observed. This presents new opportunities for pressure infusion bags which is an indispensable solution to help manage fluid infusion during home care.
Development of pressure infusion bags in the UK is gaining momentum by a growing tendency towards health care at home. The UK is also seeing its health system adapt to an increasing demand for in-home treatments by integrating a vast array of advanced medical technologies, in which pressure infusion bags are now viewed as essential part of equipment for proper, reliable, safe, and effective management of intravenous fluid infusion treatment in the home setting.
Overall, the development of home-based therapies, which are fuelling the growth of the pressure infusion bags market in the UK, is projected to increase in prevalence given the patient-centric healthcare approach, and the continuing advancements in medical technology.
Substantial investments in the pressure infusion bags market are increasingly focused on acquisitions and expansion to drive growth and strengthen market presence. Companies are prioritizing the acquisition of innovative technologies and products to enhance their offerings, while also pursuing strategic partnerships to expand their global footprint.
Recent Industry Developments in Pressure Infusion Bags Market
| Report Attributes | Details |
|---|---|
| Current Total Market Size (2025) | USD 388.2 million |
| Projected Market Size (2035) | USD 707.7 million |
| CAGR (2025 to 2035) | 6.2% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Quantitative Units | Revenue in USD |
| By Product | Disposable Pressure Infusion Bags (65.2% market share in 2024), Reusable Pressure Infusion Bags |
| By Capacity | 500cc, 1000cc, 3000cc, Above 3000cc |
| By Material | Nylon, Polyurethane, Latex, Others |
| By Application | Blood & Drug Infusion (73.1% market share in 2024), Invasive Pressure Monitoring Procedure |
| By Indication | Trauma Induced Hemorrhage, Obstetric Hemorrhage, Coagulopathy During Cardiopulmonary Bypass |
| By End-User | Hospitals, Outpatient Facilities, Clinics, Long-Term Centers |
| Regions Covered | North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, Middle East & Africa |
| Countries Covered | United States, Canada, Brazil, France, Russia, Japan, South Korea, Spain, China, UK |
| Key Players influencing the Pressure Infusion Bags Market | Vyaire Medical Inc., Smiths Medical, Inc., Merit Medical Systems, Inc., Salter Labs, VBM Medizintechnik GmbH, AirLife, Statcorp Medical, Spengler SAS, Rudolf Riester GmbH, Friedrich Bosch GmbH & Co. KG |
| Additional Attributes | Tier Structure, Semi-Annual CAGR Analysis, Material Innovation Insights |
| Customization and Pricing | Available upon Request |
In terms of product, the industry is divided into disposable pressure infusion bags and reusable pressure infusion bags.
In terms of capacity, the industry is segregated into 500cc, 1000cc, 3000cc and above 3000cc.
In terms of material, the industry is segregated into nylon, polyurethane, latex and others.
In terms of application, the industry is segregated into blood & drug infusion and invasive pressure monitoring procedure.
In terms of indication, the industry is segregated into trauma induced hemorrhage, obstetric hemorrhage and coagulopathy during cardiopulmonary bypass.
The industry is classified by end user as hospitals, outpatient facilities, clinics and long-term centers.
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East & Africa have been covered in the report.
The global pressure infusion bag industry is projected to witness CAGR of 6.2% between 2025 and 2035.
The global pressure infusion bag industry stood at USD 360.3 million in 2024.
The global pressure infusion bag industry is anticipated to reach USD 707.7 million by 2035 end.
China is set to record the highest CAGR of 9.4% in the assessment period.
The key players operating in the global pressure infusion bag industry include Vyaire Medical Inc., VBM Medizintechnik GmbH, Merit Medical Systems, Inc., Salter Labs, AirLife, Smiths Medical, Inc., Statcorp Medical, Spengler SAS, Rudolf Riester GmbH, Friedrich Bosch GmbH & Co. KG.
Explore Similar Insights
Pressure Infusion Bags Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
